GuidelineNefrologia
[Recommendations on management of the SARS-CoV-2 coronavirus pandemic (Covid-19) in kidney transplant patients].
Abstract readPractice Guideline
In one paragraph
Guideline in Nefrologia. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers.
0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
42 citing papers in PubMed.
- Remdesivir: treatment of COVID-19 in special populations.Naunyn-Schmiedeberg's archives of pharmacology · 2024Review
- Article
- Tailoring management and immunosuppression regimen in kidney transplant recipients with COVID-19 infection: lessons from Singapore.Singapore medical journal · 2022Article
- [Update of the recommendations on the management of the SARS-CoV-2 coronavirus pandemic (COVID-19) in kidney transplant patients.]Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia · 2022Review
- Treatment with sotrovimab for SARS-CoV-2 infection in a cohort of high-risk kidney transplant recipients.Clinical kidney journal · 2022Article
- Care Recommendations for the Chronic Risk of COVID-19: Nursing Intervention for Behaviour Changes.International journal of environmental research and public health · 2022Article
- Pediatric transplantation during the COVID-19 pandemic.World journal of transplantation · 2022Review
- A review of the effect of COVID-19 on immune responses of the body.Journal of family medicine and primary care · 2022Review
- [Management of immunosuppressive therapy in kidney transplant recipients with COVID19. A multicentre national study derived form the S.E.N. COVID registry.]Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia · 2022Article
- Benefits of Inactivated Vaccine and Viral Vector Vaccine Immunization on COVID-19 Infection in Kidney Transplant Recipients.Vaccines · 2022Article
- Immunosuppression in kidney transplant recipients with COVID-19 infection - where do we stand and where are we heading?Renal failure · 2021Review
- Summary report of seven cases of COVID-19 infection in renal transplant recipients.Transplant immunology · 2021Article
- Mucormycosis associated with COVID-19 in two kidney transplant patients.Transplant infectious disease : an official journal of the Transplantation Society · 2021Article
- COVID-19 in transplant recipients: The Spanish experience.American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2021Article
- The Impact of COVID-19 Disease on Urology Practice.Surgery journal (New York, N.Y.) · 2021Review
- [Recommendations for the management of the patient with chronic renal disease with SARS-CoV-2].Enfermeria clinica · 2021Article
- Taking care of kidney transplant recipients during the COVID-19 pandemic: Experience from a medicalized hotel.Clinical transplantation · 2021Article
- Transplantation in the era of the Covid-19 pandemic: How should transplant patients and programs be handled?Reviews in medical virology · 2021Review
- COVID-19 in Kidney Transplantation.International journal of organ transplantation medicine · 2021Article
- Immunosuppressant Management in Renal Transplant Patients with COVID-19.BioMed research international · 2021Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
26 authors.
Verónica LópezUnidad de Gestión Clínica de Nefrología, Hospital Regional Universitario de Málaga, Universidad de Málaga, Instituto Biomédico de Investigación de Málaga (IBIMA), REDinREN (RD16/0009/0006), Málaga, España.
Teresa VázquezUnidad de Gestión Clínica de Nefrología, Hospital Regional Universitario de Málaga, Universidad de Málaga, Instituto Biomédico de Investigación de Málaga (IBIMA), REDinREN (RD16/0009/0006), Málaga, España.
Juana Alonso-TitosUnidad de Gestión Clínica de Nefrología, Hospital Regional Universitario de Málaga, Universidad de Málaga, Instituto Biomédico de Investigación de Málaga (IBIMA), REDinREN (RD16/0009/0006), Málaga, España.
Mercedes CabelloUnidad de Gestión Clínica de Nefrología, Hospital Regional Universitario de Málaga, Universidad de Málaga, Instituto Biomédico de Investigación de Málaga (IBIMA), REDinREN (RD16/0009/0006), Málaga, España.
Angel AlonsoServicio de Nefrología, Complejo Hospitalario A Coruña, A Coruña, España.
Isabel BeneytoServicio de Nefrología, Hospital Universitario Politécnico La Fe, Valencia, España.
Marta CrespoServicio de Nefrología, Hospital del Mar, Barcelona, España. Servicio de Nefrología, Hospital Central de Asturias, REDinREN RD16/0009/0021, Asturias, España.
Carmen Díaz-CorteServicio de Nefrología, Hospital del Mar, Barcelona, España. Servicio de Nefrología, Hospital Central de Asturias, REDinREN RD16/0009/0021, Asturias, España.
Antonio FrancoServicio de Nefrología, Hospital de Alicante, Alicante, España.
Francisco González-RonceroServicio de Nefrología, Hospital Virgen del Rocío, Sevilla, España.
Elena GutiérrezUnidad de Gestión Clínica de Nefrología, Hospital Regional Universitario de Málaga, Universidad de Málaga, Instituto Biomédico de Investigación de Málaga (IBIMA), REDinREN (RD16/0009/0006), Málaga, España.
Luis GuiradoServicio de Nefrología, Fundación Puigvert, REDinREN RD16/0009/0019, Barcelona, España.
Carlos JiménezServicio de Nefrología, Hospital La Paz, Madrid, España.
Cristina JirondaUnidad de Gestión Clínica de Nefrología, Hospital Regional Universitario de Málaga, Universidad de Málaga, Instituto Biomédico de Investigación de Málaga (IBIMA), REDinREN (RD16/0009/0006), Málaga, España.
Ricardo LauzuricaServicio de Nefrología, Hospital Trias i Pujol, REDinREN RD16/0009/0032, Barcelona, España.
Santiago LlorenteServicio de Nefrología, Hospital Virgen de la Arrixaca, Murcia, España.
Auxiliadora MazuecosServicio de Nefrología, Hospital Universitario Puerta del Mar, Cádiz, España.
Javier PaulServicio de Nefrología, Hospital Miguel Servet, Zaragoza, España.
Alberto Rodríguez-BenotServicio de Nefrología, Hospital Reina Sofía, Instituto Maimónides de Investigación Biomédica de Córdoba, Córdoba, España.
Juan Carlos RuizServicio de Nefrología, Hospital Marqués de Valdecilla, IDIVAL, REDinREN RD16/0009/0027, Santander, España.
Ana Sánchez-FructuosoServicio de Nefrología, Hospital Clínico San Carlos, Universidad Complutense de Madrid, Madrid, España.
Eugenia SolaUnidad de Gestión Clínica de Nefrología, Hospital Regional Universitario de Málaga, Universidad de Málaga, Instituto Biomédico de Investigación de Málaga (IBIMA), REDinREN (RD16/0009/0006), Málaga, España.
Vicente TorregrosaServicio de Nefrología, Hospital Clínic, Barcelona, España.
Sofía ZárragaServicio de Nefrología, Hospital de Cruces, Bilbao, España.
Domingo HernándezUnidad de Gestión Clínica de Nefrología, Hospital Regional Universitario de Málaga, Universidad de Málaga, Instituto Biomédico de Investigación de Málaga (IBIMA), REDinREN (RD16/0009/0006), Málaga, España. Electronic address: domingohernandez@gmail.com.
Grupo de Estudio GREAT (Grupo Español de Actualizaciones en Trasplante)
Funding
No grant is acknowledged in the PubMed record.
Abstract
The SARS-CoV-2 (Covid-19) coronavirus pandemic is evolving very quickly and means a special risk for both immunosuppressed and comorbid patients. Knowledge about this growing infection is also increasing although many uncertainties remain, especially in the kidney transplant population. This manuscript presents a proposal for action with general and specific recommendations to protect and prevent infection in this vulnerable population such as kidney transplant recipients.
Indexed as
BetacoronavirusImmunocompromised HostKidneyPatient Education as TopicTransplant RecipientsComorbidityCoronavirus InfectionsCOVID-19HumansImmunosuppressive AgentsPandemicsPneumonia, ViralRisk FactorsSARS-CoV-2SpainImmunosuppressive AgentsCovid-19ImmunosuppressedInmunodeprimidoKidney transplantationSARS-CoV-2Trasplante renal
Identifiers
What OpenQuestion holds
Textmetadata
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.